StreetInsider.com After-Hours Movers 10/02

StreetInsider.com After-Hours Movers:

Metabasis Therapeutics (Nasdaq: MBRX) 15.8% HIGHER; announced today that MB07133 has been granted orphan medicinal product status for the treatment of hepatocellular carcinoma (HCC), or primary liver cancer, by the European Commission (EC). This designation is based on a recommendation from the Committee for Orphan Medicinal Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA).

Midway Games Inc. (NYSE: MWY) 6.4% LOWER; now expects third quarter revenue of approximately $39 million, as compared to the Company's previous estimate of approximately $50 million, and a net loss of $0.33 per basic and diluted share, compared to the Company's previous estimate of a net loss of approximately $0.23 per basic and diluted share. On a non-GAAP basis, the Company now expects a loss of approximately $0.27 per basic and diluted share, compared to the Company's prior estimate of $0.17 per basic and diluted share. A reconciliation of non-GAAP to GAAP guidance is provided in a table at the end of this press release.

Micron Technology Inc. (NYSE: MU) 3.2% LOWER; reports a Q4 loss of $0.21 per share, versus the consensus of a $0.22. Revenues came in at $1.4 billion versus the consensus of $1.4 billion.

You May Also Be Interested In

• Citi expects ’continued memory undersupply’ in 2027
• China pledges to reduce trade tensions with Canada
• Cirrus Logic falls on weak third quarter revenue guidance